Robert Dubois, MD
Articles
May 7th 2018
Impact of Formulary Restrictions on Medication Intensification in Diabetes Treatment
Bruce C. Stuart, PhD Julia F. Slejko, PhD Juan-David Rueda, MD Catherine E. Cooke, PharmD Xian Shen, PhD Pamela Roberto, PhD Michael Ciarametaro, MBA Robert Dubois, MD
Formulary restrictions on brand name noninsulin antihyperglycemic drugs have little impact on treatment intensification patterns among low-income patients with diabetes in Medicare Part D.
June 30th 2014
Real-World Impact of Comparative Effectiveness Research Findings on Clinical Practice
Teresa B. Gibson, PhD Emily D. Ehrlich, MPH Jennifer Graff, PharmD Robert Dubois, MD Amanda M. Farr, MPH Michael E. Chernew, PhD A. Mark Fendrick, MD
The authors found no consistent pattern in the concordance between CER evidence and subsequent utilization patterns.
Latest Updated Articles
Published: August 18th 2025 | Updated: August 25th 2025
Conditional Economic Incentives Could Be Effective in Improving Adherence to Long-Acting PrEP in Transgender Adults
Published: August 19th 2025 | Updated: August 22nd 2025
Semaglutide Not Associated With Increased Risk of Eye Disorders
Published: June 6th 2025 | Updated: August 18th 2025
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
Published: June 27th 2025 | Updated: July 1st 2025
Report Reveals Mounting Burdens of Drug Shortages on US Health System
Published: February 20th 2025 | Updated: February 21st 2025
Managed Care Reflections: Insights From Richard J. Gilfillan, MD; and Donald M. Berwick, MD, MPP
Published: January 16th 2025 | Updated: January 29th 2025
FDA Proposal Aims to Reduce Smoking Addiction and SCLC Cases
